Parallel Advisors, LLC Haemonetics Corp Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 173 shares of HAE stock, worth $15,699. This represents 0.0% of its overall portfolio holdings.

Number of Shares

173

Previous 184 5.98%

Holding current value

$15,699

Previous $15,000 13.33%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$72.45 - $91.58 $796 - $1,007	-11 Reduced 5.98%	173 $13,000
Q2 2024 Aug 08, 2024	SELL	$81.24 - $97.37 $243 - $292	-3 Reduced 1.6%	184 $15,000
Q1 2024 May 06, 2024	BUY	$71.24 - $85.35 $427 - $512	6 Added 3.31%	187 $15,000
Q4 2023 Feb 09, 2024	SELL	$80.59 - $92.61 $4,190 - $4,815	-52 Reduced 22.32%	181 $15,000
Q2 2023 May 20, 2024	SELL	$80.84 - $89.45 $404 - $447	-5 Reduced 2.1%	233 $19,000
Q2 2023 Aug 04, 2023	SELL	$80.84 - $89.45 $404 - $447	-5 Reduced 2.1%	233 $19,000
Q1 2023 May 20, 2024	BUY	$72.75 - $90.6 $3,710 - $4,620	51 Added 27.27%	238 $19,000
Q1 2023 Apr 25, 2023	SELL	$72.75 - $90.6 $8,002 - $9,966	-110 Reduced 31.61%	238 $19,000
Q4 2022 Feb 03, 2023	BUY	$73.85 - $86.14 $664 - $775	9 Added 2.65%	348 $27,000
Q3 2022 Nov 10, 2022	BUY	$63.3 - $78.66 $6,519 - $8,101	103 Added 43.64%	339 $25,000
Q2 2022 Aug 01, 2022	BUY	$49.27 - $66.08 $394 - $528	8 Added 3.51%	236 $15,000
Q1 2022 Apr 28, 2022	BUY	$43.77 - $63.22 $306 - $442	7 Added 3.17%	228 $14,000
Q4 2021 Jan 20, 2022	SELL	$49.55 - $74.59 $9,414 - $14,172	-190 Reduced 46.23%	221 $12,000
Q3 2021 Nov 02, 2021	BUY	$57.6 - $70.59 $14,572 - $17,859	253 Added 160.13%	411 $29,000
Q2 2021 Aug 06, 2021	SELL	$51.81 - $118.56 $259 - $592	-5 Reduced 3.07%	158 $11,000
Q1 2021 Apr 23, 2021	SELL	$111.01 - $139.48 $222 - $278	-2 Reduced 1.21%	163 $18,000
Q4 2020 Feb 02, 2021	BUY	$88.75 - $119.95 $2,840 - $3,838	32 Added 24.06%	165 $20,000
Q4 2019 Jan 30, 2020	SELL	$114.37 - $129.46 $1,601 - $1,812	-14 Reduced 9.52%	133 $15,000
Q3 2019 Nov 01, 2019	BUY	$117.16 - $138.52 $1,640 - $1,939	14 Added 10.53%	147 $19,000
Q3 2018 Nov 01, 2018	SELL	$89.96 - $114.58 $1,079 - $1,374	-12 Reduced 8.28%	133 $15,000
Q3 2017 Nov 15, 2017	BUY	$40.38 - $44.87 $5,855 - $6,506	145 New	145 $8,000
Q3 2017 Nov 14, 2017	SELL	$40.38 - $44.87 $5,855 - $6,506	-145 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	145	145 $6,000

Others Institutions Holding HAE

# of Institutions

331

Shares Held

54.1M

Call Options Held

609K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.66B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Haemonetics Corp Transaction History